Clinical Trial Update: Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies

View source ↗

Summary

This update describes a clinical trial focused on isolating human recombinant monoclonal antibodies against Pseudomonas aeruginosa. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Anti-Pseudomonas monoclonal antibodies (uncharacterized)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Pseudomonas Aeruginosa, Multi-antibiotic Resistance | Status: RECRUITING